«Gefitinib (ZD1839) (INN, /ɡɛˈfɪtɪnɪb/, trade name Iressa)[1] is a drug used for certain breast, lung and other cancer. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancer with mutated and overactive EGFR. It is marketed by AstraZeneca and Teva.» (wikipedia)

  • Subnodes

Modified: 1 month ago on Jul 7, 2019
personMoreVitaminov 16 lvl added it 2 months ago on Jun 18, 2019.